Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

3.3K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Basal Lamina are the Specialized Form of ECM01:03

Basal Lamina are the Specialized Form of ECM

4.1K
The basal lamina is a thin extracellular layer that lies underneath the cells and separates them from other tissues. The three layers of the basal lamina are lamina lucida, lamina densa and lamina reticularis. The basal lamina, a mixture of glycoproteins and collagen, provides an attachment site for the epithelium, separating it from underlying connective tissue. The framework of basal lamina has other essential proteins such as laminins mesh, perlecan, entactin, and type IV collagen.
Proteins...
4.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The extracellular matrix as a central regulator of aging and tissue adaptation to exercise.

American journal of physiology. Cell physiology·2026
Same author

N-acetylcysteine exerts senescence-selective antifibrotic effects in fibroblast from chronic wounds in Recessive Dystrophic Epidermolysis Bullosa.

The British journal of dermatology·2026
Same author

Generation of high-expressing transposon-based stable pools to produce (1 + 1) and (2 + 1) bispecific common light chain antibodies.

Biotechnology progress·2026
Same author

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Molecular therapy. Advances·2026
Same author

Impaired skin reinnervation in Epidermolysis Bullosa due to neurotrophic deficiency.

Pain·2026
Same author

Transforming Growth Factor-β-Mediated Fibrotic Remodeling Drives Chronic Kidney Disease in Methylmalonic Aciduria and Propionic Aciduria-Identification of a New Therapeutic Target.

Journal of inherited metabolic disease·2025

Related Experiment Video

Updated: Mar 15, 2026

Confocal and Super-Resolution Imaging of Polarized Intracellular Trafficking and Secretion of Basement Membrane Proteins During Drosophila Oogenesis
10:41

Confocal and Super-Resolution Imaging of Polarized Intracellular Trafficking and Secretion of Basement Membrane Proteins During Drosophila Oogenesis

Published on: May 19, 2022

2.6K

Cell therapy for basement membrane-linked diseases.

Alexander Nyström1, Olivier Bornert1, Tobias Kühl1

  • 1Department of Dermatology, Medical Center - University of Freiburg, Freiburg, Germany.

Matrix Biology : Journal of the International Society for Matrix Biology
|September 10, 2016
PubMed
Summary
This summary is machine-generated.

Cell-based therapies offer promising treatments for genetic basement membrane (BM) disorders by using cells as transient protein replacement vehicles. These therapies can address causal mechanisms and secondary conditions, though wider clinical use requires overcoming current challenges.

Keywords:
Basement membraneKidneyMuscleRare diseasesSkinTherapy

More Related Videos

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation
07:30

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation

Published on: June 28, 2024

1.9K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

Confocal and Super-Resolution Imaging of Polarized Intracellular Trafficking and Secretion of Basement Membrane Proteins During Drosophila Oogenesis
10:41

Confocal and Super-Resolution Imaging of Polarized Intracellular Trafficking and Secretion of Basement Membrane Proteins During Drosophila Oogenesis

Published on: May 19, 2022

2.6K
Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation
07:30

Basement Membrane Matrix Encapsulated Cell Aggregation for Investigating Murine Spleen Tissue Formation

Published on: June 28, 2024

1.9K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.4K

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Genetics

Background:

  • Genetic disorders of basement membrane (BM) proteins currently have limited treatment options.
  • BM proteins are extracellular, making them suitable targets for cell-based protein replacement therapy.
  • Secondary disease mechanisms in BM disorders can also be targeted by cell therapies.

Purpose of the Study:

  • To review the current status of cell-based therapies for genetic basement membrane (BM) disorders.
  • To discuss the potential of cell therapies in addressing both primary genetic defects and secondary disease mechanisms.
  • To explore the challenges and future directions for implementing cell therapies in clinical practice for BM-linked diseases.

Main Methods:

  • Review of existing literature on cell therapies for BM-linked genetic disorders.
  • Discussion of the use of pluripotent and differentiated cells for therapeutic applications.
  • Analysis of limitations, challenges, and potential strategies for wider clinical implementation.

Main Results:

  • Cell-based approaches can serve as transient vehicles for protein replacement in BM disorders.
  • Cell therapies have the potential to address both the root cause and secondary mechanisms of BM-linked diseases.
  • Significant potential exists for cell therapies, but realization in clinical practice is currently limited.

Conclusions:

  • Cell-based therapies hold considerable promise for treating genetic basement membrane (BM) disorders due to their ability to provide protein replacement and target secondary mechanisms.
  • Overcoming current limitations and challenges is crucial for the wider clinical implementation of these therapies.
  • Further research and development are needed to fully realize the therapeutic potential of cell-based approaches for BM-linked diseases.